Receptor tyrosine kinases as targets for anticancer drugs

By Zwick E.   Bange J.   Ullrich A.  

Trends in Molecular Medicine, Vol. 8, Iss. 1, 2002-01 ,pp. : 17-23

Elsevier

Access to resources Recommend Favorite

Tyrosine kinases in AML: where do they fit in?

By Ilaria R.L.  

Leukemia Research, Vol. 28, Iss. 3, 2004-03 ,pp. : 217-218

Elsevier

Access to resources Recommend Favorite

EGF and PDGF Receptor Tyrosine Kinases as Therapeutic Targets for Chronic Lung Diseases

By  

Current Molecular Medicine, Vol. 6, Iss. 4, 2006-06 ,pp. : 409-421

Bentham Science Publishers

Access to resources Recommend Favorite

Reciprocal regulation of protein tyrosine kinases p56 lck and p59 fyn , and altered tyrosine phosphorylation in murine AIDS

By Lambert C.  

International Immunology, Vol. 10, Iss. 10, 1998-10 ,pp. : 1473-1480

Oxford University Press

Access to resources Recommend Favorite

Evidence For A Functional Contribution of Adenosine Signalling in Inflammatory Airway Diseases

By  

Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Immunology, Endocrine and Metabolic Agents), Vol. 7, Iss. 4, 2007-08 ,pp. : 286-297

Bentham Science Publishers

Access to resources Recommend Favorite